Daxor Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Daxor Corporation (DXR)
Daxor Corporation stock price live, this page displays NASDAQ DXR stock exchange data. View the DXR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Daxor Corporation real time stock price chart below.
What Is the Daxor Corporation Stock Price Today?
The Daxor Corporation stock price today is 10.62.
What Is the Stock Symbol for Daxor Corporation?
The stock symbol for Daxor Corporation is "DXR."
What Stock Exchange Does Daxor Corporation Trade On?
Daxor Corporation is listed and trades on the NASDAQ stock exchange.
Is Daxor Corporation a Good Stock to Buy?
Determining whether Daxor Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DXR quote. (ISIN: US2394671034)
What Is the Daxor Corporation Stock Price Today?
The Daxor Corporation stock price today is 10.62.
What Is the Stock Symbol for Daxor Corporation?
The stock symbol for Daxor Corporation is "DXR."
What Stock Exchange Does Daxor Corporation Trade On?
Daxor Corporation is listed and trades on the NASDAQ stock exchange.
Is Daxor Corporation a Good Stock to Buy?
Determining whether Daxor Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DXR quote. (ISIN: US2394671034)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.50
10.79
52 wk Range
8.56
14.76
DXR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.5010.79
52 wk Range
8.5614.76
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DXR Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
20.00
Upside
+88.32%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Niche player in the %INDUSTRY% industry
Form 4 Daxor Corp For: 25 June- Investing.com
- Daxor Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 20.00
(+88.32% Upside)
Daxor Corporation Earnings Call Summary for Q4/2024
- Revenue surged 116.5% year-over-year in Q4 2024; company achieved cash flow breakeven in Q1 2025
- Stock price rose 3.6% post-announcement; analysts set $24.75 price target, suggesting significant upside potential
- Developing next-generation blood volume analyzer; plans to resubmit for FDA approval and file for CLIA waiver in 2025
- Expanded market presence with new accounts and increased kit sales; less than 1% of potential market currently reached
- Transitioning from 1940 Act to 1934 Act company designation to enhance market positioning
Last Updated: 2025-03-06, 05:08 p/m
Read Full TranscriptEarnings
Latest Release
Aug 20, 2026
EPS / Forecast
-0.06 / -0.03
Revenue / Forecast
2M / 2.8M
Compare DXR to Peers and Sector
Metrics to compare | DXR | Sector Sector - Average of metrics from a broad group of related Financial sector companies | Relationship RelationshipDXRPeersSector | |
|---|---|---|---|---|
P/E Ratio | 10.0x | −0.8x | −0.3x | |
PEG Ratio | 0.05 | −0.13 | 0.00 | |
Price/Book | 1.2x | 2.1x | 2.6x | |
Price / LTM Sales | 1,977.1x | 1.8x | 3.0x | |
Upside (Analyst Target) | 88.3% | 27.9% | 58.6% | |
Fair Value Upside | Unlock | 3.2% | 8.4% | Unlock |
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Daxor (DXR) Stock Price Today?
The Daxor stock price today is 10.62 USD.
What Stock Exchange Does Daxor Trade On?
Daxor is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Daxor?
The stock symbol for Daxor is "DXR."
What Is the Daxor Market Cap?
As of today, Daxor market cap is 64.10M USD.
What Is Daxor's Earnings Per Share (TTM)?
The Daxor EPS (TTM) is 1.07.
When Is the Next Daxor Earnings Date?
Daxor will release its next earnings report on Nov 12, 2026.
From a Technical Analysis Perspective, Is DXR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Daxor Stock Split?
Daxor has split 0 times.
How Many Employees Does Daxor Have?
Daxor has 45 employees.
What is the current trading status of Daxor (DXR)?
As of Oct 04, 2026, Daxor (DXR) is trading at a price of 10.62 USD, with a previous close of 10.98 USD. The stock has fluctuated within a day range of 10.50 USD to 10.79 USD, while its 52-week range spans from 8.56 USD to 14.76 USD.
What Is Daxor (DXR) Price Target According to Analysts?
The average 12-month price target for Daxor is 20.00 USD, with a high estimate of 22 USD and a low estimate of 18 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +88.32% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.